Choksi Laboratories [CHOKSILA] vs Dr. Lal PathLabs [LALPATHLAB] Detailed Stock Comparison

Choksi Laboratories Ltd.

BSE
Loading...

Dr. Lal PathLabs Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Choksi Laboratories Ltd. wins in 8 metrics, Dr. Lal PathLabs Ltd. wins in 11 metrics, with 0 ties. Dr. Lal PathLabs Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Choksi Laboratories Ltd. Dr. Lal PathLabs Ltd. Better
P/E Ratio (TTM) 37.71 46.16 Choksi Laboratories Ltd.
Price-to-Book Ratio 2.85 10.20 Choksi Laboratories Ltd.
Debt-to-Equity Ratio 120.16 6.44 Dr. Lal PathLabs Ltd.
PEG Ratio 0.19 -7.05 Choksi Laboratories Ltd.
EV/EBITDA 8.86 32.00 Choksi Laboratories Ltd.
Profit Margin (TTM) 4.17% 19.84% Dr. Lal PathLabs Ltd.
Operating Margin (TTM) 7.41% 20.79% Dr. Lal PathLabs Ltd.
EBITDA Margin (TTM) 7.41% 20.79% Dr. Lal PathLabs Ltd.
Return on Equity 6.45% 22.08% Dr. Lal PathLabs Ltd.
Return on Assets (TTM) 2.33% 17.93% Dr. Lal PathLabs Ltd.
Free Cash Flow (TTM) $40.91M $5.15B Dr. Lal PathLabs Ltd.
Dividend Yield N/A 1.56% N/A
1-Year Return 12.14% 15.37% Dr. Lal PathLabs Ltd.
Price-to-Sales Ratio (TTM) 1.58 9.15 Choksi Laboratories Ltd.
Enterprise Value $988.26M $228.83B Dr. Lal PathLabs Ltd.
EV/Revenue Ratio 2.22 8.59 Choksi Laboratories Ltd.
Gross Profit Margin (TTM) 80.48% 65.97% Choksi Laboratories Ltd.
Revenue per Share (TTM) $64 $160 Dr. Lal PathLabs Ltd.
Earnings per Share (Diluted) $2.68 $31.61 Dr. Lal PathLabs Ltd.
Beta (Stock Volatility) 0.06 0.10 Choksi Laboratories Ltd.

Choksi Laboratories Ltd. vs Dr. Lal PathLabs Ltd. Stock Performance Analysis

Loading Price Chart...

CHOKSILA
LALPATHLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Choksi Laboratories Ltd.2.83%-7.99%21.15%31.75%-6.05%-3.17%
Dr. Lal PathLabs Ltd.-0.54%-2.94%-0.24%15.45%4.81%3.96%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Choksi Laboratories Ltd.12.14%183.17%859.21%968.12%807.14%566.67%
Dr. Lal PathLabs Ltd.15.37%59.53%12.09%223.97%258.78%258.78%

Performance & Financial Health Analysis: Choksi Laboratories Ltd. vs Dr. Lal PathLabs Ltd.

MetricCHOKSILALALPATHLAB
Market Information
Market Cap i₹703.84M₹238.92B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,105392,728
90 Day Avg. Volume i4,089321,187
Last Close₹125.45₹1,561.20
52 Week Range₹81.85 - ₹236.70₹1,272.60 - ₹1,770.00
% from 52W High-47.00%-11.80%
All-Time High₹236.70 (Aug 20, 2025)₹4,245.50 (Sep 13, 2021)
% from All-Time High-47.00%-63.23%
Growth Metrics
Quarterly Revenue Growth0.04%0.11%
Quarterly Earnings Growth1.93%-0.06%
Financial Health
Profit Margin (TTM) i0.04%0.20%
Operating Margin (TTM) i0.07%0.21%
Return on Equity (TTM) i0.06%0.22%
Debt to Equity (MRQ) i120.166.44
Cash & Liquidity
Book Value per Share (MRQ)₹35.41₹143.09
Cash per Share (MRQ)₹0.45₹77.96
Operating Cash Flow (TTM) i₹51.38M₹4.66B
Levered Free Cash Flow (TTM) i₹15.23M₹4.87B
Dividends
Last 12-Month Dividend Yield iN/A1.56%
Last 12-Month Dividend iN/A₹22.50

Valuation & Enterprise Metrics Analysis: Choksi Laboratories Ltd. vs Dr. Lal PathLabs Ltd.

MetricCHOKSILA (Apr 26, 2026)LALPATHLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i37.7146.16
Forward P/E iN/A41.23
PEG Ratio i0.19-7.05
Price to Sales (TTM) i1.589.15
Price to Book (MRQ) i2.8510.20
Market Capitalization
Market Capitalization i₹703.84M₹238.92B
Enterprise Value i₹988.26M₹228.83B
Enterprise Value Metrics
Enterprise to Revenue i2.228.59
Enterprise to EBITDA i8.8632.00
Risk & Other Metrics
Beta i0.060.10
Book Value per Share (MRQ) i₹35.41₹143.09

Financial Statements Comparison: Choksi Laboratories Ltd. vs Dr. Lal PathLabs Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCHOKSILA (2025)LALPATHLAB (2025)
Revenue/Sales i417.82M24.61B
Cost of Goods Sold i46.20M8.23B
COGS % of Revenue i11.1%33.4%
Gross Profit i371.62M16.38B
Gross Margin i88.9%66.6%
Research & Development iN/AN/A
Operating Income (EBIT) i50.09M5.60B
Operating Margin i12.0%22.8%
EBITDA i115.12M7.74B
EBITDA Margin i27.6%31.5%
Pre-Tax Income i21.53M6.25B
Pre-Tax Income % of Revenue i5.2%25.4%
Income Tax i6.30M1.33B
Income Tax % of Revenue i1.5%5.4%
Net Income (Profit) i15.23M4.92B
Profit Margin i3.6%20.0%

Balance Sheet & Liquidity Metrics

MetricCHOKSILA (2025)LALPATHLAB (2025)
Cash & Equivalents i6.12M2.93B
Total Current Assets i163.21M13.64B
Total Current Assets % of Revenue i39.1%55.4%
Total Current Liabilities i238.75M4.02B
Total Current Liabilities % of Revenue i57.1%16.3%
Long-Term Debt i159.63M1.03B
Long-Term Debt % of Revenue i38.2%4.2%
Total Shareholders Equity i236.05M22.06B
Retained Earnings i150.56M18.60B
Retained Earnings % of Revenue i36.0%75.6%
Property, Plant & Equipment i471.35M3.36B

Cash Flow Statement Comparison

MetricCHOKSILA (2025)LALPATHLAB (2025)
Operating Cash Flow i51.38M4.66B
Operating Cash Flow % of Revenue i12.3%18.9%
Capital Expenditures i-74.37M-436.20M
Free Cash Flow i40.91M5.15B
FCF Margin i9.8%20.9%
Debt Repayment i-58.75M-833.34M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCHOKSILALALPATHLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i6.97M166.97M
Float Shares i3.14M75.55M
% Held by Insiders i60.49%54.91%
% Held by Institutions i0.00%31.54%
% Held by Public i39.51%13.55%

Dividend Analysis & Yield Comparison: Choksi Laboratories Ltd. vs Dr. Lal PathLabs Ltd.

MetricCHOKSILALALPATHLAB
Last 12-Month Dividend iN/A₹22.50
Last 12-Month Dividend Yield iN/A1.56%
3-Year Avg Annual Dividend iN/A₹23.50
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends iN/A₹70.50
Ex-Dividend DateN/AFeb 05, 2026